ラット・マウスモデル市場：モデルタイプ、技術、サービス、治療領域、エンドユーザー別-2025-2030年世界予測

ラット・マウスモデル市場の2023年の市場規模は22億7,000万米ドルで、2024年には24億5,000万米ドルに達すると予測され、CAGR 8.26％で成長し、2030年には39億7,000万米ドルに達すると予測されています。

ラット・マウスモデル市場は、生物医学研究において重要な役割を果たしており、これらのげっ歯類とヒトとの間の遺伝的・生物学的類似性により、ヒトの疾病メカニズムに対する貴重な洞察を提供しています。これらのモデルは、疾患の進行、薬物相互作用、遺伝子発現の研究に不可欠であり、医薬品やバイオテクノロジー産業の前臨床試験において必要不可欠です。応用範囲は腫瘍学、心臓病学、神経科学、免疫学、遺伝学研究に及び、エンドユーザーには研究機関、製薬会社、受託研究機関などが含まれます。現在、市場の成長を後押ししているのは、遺伝子工学技術の進歩、研究開発投資の増加、革新的な治療法を必要とする慢性疾患の増加です。個別化医療に開発機会があり、マウスモデルをカスタマイズすることで標的治療の開発を加速できます。さらに、CRISPR-Cas9技術の台頭と遺伝子改変によるヒト化マウスモデルの利用拡大が、研究能力を拡大し、有利な成長の道を提供します。しかし、市場の拡大は、動物実験に関する倫理的懸念、規制上の課題、代替のin vitroおよびin silicoモデルへの移行によって制約されています。また、生きた動物のコロニー維持に伴う複雑さとコストも大きな制約となっています。このような機会を活用するため、利害関係者はAIと機械学習を統合し、動物実験からのデータ解析の有効性を高めることに注力すべきです。頑健な試験管内シミュレーション技術の開発は、従来の動物モデルを補完し、それに取って代わる可能性があり、変化する規制・倫理基準との整合性を確保することができます。イノベーションはまた、モデルの精度と関連性を向上させるための遺伝子操作手順の改良にも焦点を当てるべきです。現在、ラット・マウスモデル市場は堅調な需要見通しの恩恵を受けているもの、技術の進歩や倫理観の変化により、ダイナミックな未来に直面しており、この分野のプレーヤーには適応戦略が求められています。継続的なイノベーションと戦略的適応により、この市場は大きな成長の可能性を秘めています。

市場力学：急速に進化するラット・マウスモデル市場の主要市場インサイトを公開

ラット・マウスモデル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 治療標的を検証するための遺伝子組み換えモデルに対する大きな需要
  • 製薬・バイオテクノロジー分野における研究開発費の増加
  • 個別化医療に対する需要の急増
• 市場抑制要因
  • 倫理的懸念とラット・マウスモデルの制限
• 市場機会
  • ヒト化ラット・マウスモデルへの傾斜
  • 成長する治療研究分野
• 市場の課題
  • 代替検査法の存在

ポーターのファイブフォース：ラット・マウスモデル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ラット・マウスモデル市場における外部からの影響の把握

外部マクロ環境要因は、ラット・マウスモデル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ラット・マウスモデル市場における競合情勢の把握

ラット・マウスモデル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスラット・マウスモデル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ラット・マウスモデル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ラット・マウスモデル市場における成功への道筋を描く

ラット・マウスモデル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 治療ターゲットを検証するための遺伝子組み換えモデルに対する大きな需要
    • 医薬品およびバイオテクノロジー分野の研究開発活動における支出の増加
    • 個別化医療の需要急増
  • 抑制要因
    • ラット・マウスモデルの倫理的懸念と限界
  • 機会
    • 人間味あふれるテーマへの傾倒
    • 成長する治療調査分野
  • 課題
    • 代替試験方法の存在
• 市場セグメンテーション分析
  • モデルタイプ：遺伝子組み換えラットによってもたらされる遺伝機能と遺伝性疾患の発症に関する重要な洞察
  • サービス：特定の遺伝的背景を生み出す必要性から、繁殖サービスのためのラットおよびマウスモデルの使用を拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ラット・マウスモデル市場モデルタイプ別

• 条件付けまたは外科手術で改変されたラット
• 遺伝子組み換えラット
• ハイブリッドまたはコンジェニックラット
• 免疫不全ラット
• 近親交配したネズミ
• 異系交配したネズミ

第7章 ラット・マウスモデル市場：技術別

• クリスパー
• 胚性幹細胞注入
• マイクロインジェクション
• 核移植

第8章 ラット・マウスモデル市場：サービス別

• 育種
• 凍結保存
• 遺伝子検査
• モデルインライセンス
• 検疫
• 再派生

第9章 ラット・マウスモデル市場治療領域別

• 心血管疾患
• 糖尿病
• 免疫学と炎症
• 神経学
• 腫瘍学
• 毒物学

第10章 ラット・マウスモデル市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのラット・マウスモデル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のラット・マウスモデル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのラット・マウスモデル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • チャールズリバーラボラトリーズによる高度な遺伝子組み換えマウスモデルによる前臨床調査の強化
  • 革新的なマウスモデルが慢性リンパ性白血病とリヒター変換の新たな治療法への道を開く
  • 虚弱性と老化におけるIL-6の役割を解明するためのマウスモデルの開拓
• 戦略分析と提言

企業一覧

• Allentown, Inc.
• Aragen Life Sciences
• Biocytogen
• Biomere Biomedical Research Models, Inc.
• Champions Oncology, Inc.
• Charles River Laboratories International, Inc.
• Crown Bioscience, Inc. by JSR Corp.
• Cyagen US Inc.
• Envigo by Inotiv, Inc.
• GemPharmatech
• GenOway S.A.
• Harbour Biomed
• Hera BioLabs
• Ingenious Targeting Laboratory
• Janvier Labs
• Oncodesign Precision Medicine
• Ozgene Pty Ltd.
• PerkinElmer, Inc.
• Pharmatest Services Oy
• PolyGene AG
• Taconic Biosciences, Inc.
• The Jackson Laboratory
• TransCure Bioservices
• TransViragen, Inc.
• Vivo Bio Tech Ltd.

LIST OF FIGURES

• FIGURE 1. RAT & MOUSE MODEL MARKET RESEARCH PROCESS
• FIGURE 2. RAT & MOUSE MODEL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RAT & MOUSE MODEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RAT & MOUSE MODEL MARKET DYNAMICS
• TABLE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONDITIONED OR SURGICALLY MODIFIED RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETICALLY MODIFIED RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY HYBRID OR CONGENIC RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNODEFICIENT RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INBRED RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY OUTBRED RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BREEDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL-IN-LICENSING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY QUARANTINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REDERIVATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. CANADA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 57. CANADA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. CHINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. CHINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 84. CHINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. INDIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. INDIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. INDIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 89. INDIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 119. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 124. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 129. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 134. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 145. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 150. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 155. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 160. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 165. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 170. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. ITALY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. ITALY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. ITALY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 174. ITALY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 175. ITALY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 180. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 185. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 190. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. POLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 192. POLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. POLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 194. POLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 195. POLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. QATAR RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 197. QATAR RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. QATAR RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 199. QATAR RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 200. QATAR RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 205. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 210. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 220. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 225. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 230. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 235. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 240. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 245. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 247. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

The Rat & Mouse Model Market was valued at USD 2.27 billion in 2023, expected to reach USD 2.45 billion in 2024, and is projected to grow at a CAGR of 8.26%, to USD 3.97 billion by 2030.

The rat and mouse model market serves a crucial role in biomedical research, offering a valuable insight into human disease mechanisms due to genetic and biological similarities between these rodents and humans. These models are essential for studying disease progression, drug interactions, and genetic expressions, thus a necessity in preclinical trials for pharmaceuticals and biotechnology industries. The application scope spans across oncology, cardiology, neuroscience, immunology, and genetic research, with end-users including research institutions, pharmaceutical companies, and contract research organizations. Currently, market growth is propelled by advancements in genetic engineering technologies, rising R&D investments, and an increasing prevalence of chronic diseases necessitating innovative therapeutics. Opportunities lie in personalized medicine, where customized mouse models can accelerate the development of targeted therapies. Additionally, the rise of CRISPR-Cas9 technology and expanded use of humanized mouse models through genetic modification broaden research capabilities, offering lucrative growth avenues. However, market expansion is constrained by ethical concerns regarding animal testing, regulatory challenges, and the transition towards alternative in vitro and in silico models. The complexity and cost associated with maintaining live animal colonies are also significant limitations. To capitalize on these opportunities, stakeholders should focus on integrating AI and machine learning to enhance data analysis efficacy from animal studies. Developing robust in vitro simulation techniques can complement and potentially replace traditional animal models, ensuring alignment with changing regulatory and ethical standards. Innovation should also focus on refining genetic manipulation procedures to improve model accuracy and relevance. While currently benefitting from a robust demand outlook, the rat and mouse model market faces a dynamic future, driven by technological advancements and shifting ethical perspectives, demanding adaptive strategies from players in the sector. Through continuous innovation and strategic adaptation, the market promises significant growth potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Rat & Mouse Model Market

The Rat & Mouse Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant demand for genetically modified models to validate therapeutic targets
  • Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
  • Surge in demand for personalized medicine
• Market Restraints
  • Ethical concerns and limitation of rat & mouse model
• Market Opportunities
  • Inclination towards humanized rat & mouse model
  • Growing therapeutic research areas
• Market Challenges
  • Presence of alternative testing methods

Porter's Five Forces: A Strategic Tool for Navigating the Rat & Mouse Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Rat & Mouse Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Rat & Mouse Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Rat & Mouse Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Rat & Mouse Model Market

A detailed market share analysis in the Rat & Mouse Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Rat & Mouse Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Rat & Mouse Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Rat & Mouse Model Market

A strategic analysis of the Rat & Mouse Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Rat & Mouse Model Market, highlighting leading vendors and their innovative profiles. These include Allentown, Inc., Aragen Life Sciences, Biocytogen, Biomere Biomedical Research Models, Inc., Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc. by JSR Corp., Cyagen US Inc., Envigo by Inotiv, Inc., GemPharmatech, GenOway S.A., Harbour Biomed, Hera BioLabs, Ingenious Targeting Laboratory, Janvier Labs, Oncodesign Precision Medicine, Ozgene Pty Ltd., PerkinElmer, Inc., Pharmatest Services Oy, PolyGene AG, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, TransViragen, Inc., and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Rat & Mouse Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Model Type, market is studied across Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats, Immunodeficient Rats, Inbred Rats, and Outbred Rats.
• Based on Technology, market is studied across CRISPR, Embryonic Stem Cell Injection, Microinjection, and Nuclear Transfer.
• Based on Service, market is studied across Breeding, Cryopreservation, Genetic Testing, Model-in-Licensing, Quarantine, and Rederivation.
• Based on Therapeutic Area, market is studied across Cardiovascular Disease, Diabetes, Immunology & Inflammation, Neurology, Oncology, and Toxicology.
• Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant demand for genetically modified models to validate therapeutic targets
    • 5.1.1.2. Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
    • 5.1.1.3. Surge in demand for personalized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. Ethical concerns and limitation of rat & mouse model
  • 5.1.3. Opportunities
    • 5.1.3.1. Inclination towards humanized rat & mouse model
    • 5.1.3.2. Growing therapeutic research areas
  • 5.1.4. Challenges
    • 5.1.4.1. Presence of alternative testing methods
• 5.2. Market Segmentation Analysis
  • 5.2.1. Model Type: Significant critical insights provided by genetically modified rats into genetic functions and pathogenesis of genetic diseases
  • 5.2.2. Service: Expanding usage of rat and mouse models for breeding services due to the necessity to produce specific genetic backgrounds
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Rat & Mouse Model Market, by Model Type

• 6.1. Introduction
• 6.2. Conditioned or Surgically Modified Rats
• 6.3. Genetically Modified Rats
• 6.4. Hybrid or Congenic Rats
• 6.5. Immunodeficient Rats
• 6.6. Inbred Rats
• 6.7. Outbred Rats

7. Rat & Mouse Model Market, by Technology

• 7.1. Introduction
• 7.2. CRISPR
• 7.3. Embryonic Stem Cell Injection
• 7.4. Microinjection
• 7.5. Nuclear Transfer

8. Rat & Mouse Model Market, by Service

• 8.1. Introduction
• 8.2. Breeding
• 8.3. Cryopreservation
• 8.4. Genetic Testing
• 8.5. Model-in-Licensing
• 8.6. Quarantine
• 8.7. Rederivation

9. Rat & Mouse Model Market, by Therapeutic Area

• 9.1. Introduction
• 9.2. Cardiovascular Disease
• 9.3. Diabetes
• 9.4. Immunology & Inflammation
• 9.5. Neurology
• 9.6. Oncology
• 9.7. Toxicology

10. Rat & Mouse Model Market, by End-User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Rat & Mouse Model Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Rat & Mouse Model Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Rat & Mouse Model Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Enhancing Preclinical Research through Advanced Genetically Modified Mouse Models by Charles River Laboratories
  • 14.3.2. Innovative Mouse Model Paves Way for New Therapies in Chronic Lymphocytic Leukaemia and Richter Transformation
  • 14.3.3. Pioneering a Mouse Model to Elucidate the Role of IL-6 in Frailty and Aging
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Allentown, Inc.
• 2. Aragen Life Sciences
• 3. Biocytogen
• 4. Biomere Biomedical Research Models, Inc.
• 5. Champions Oncology, Inc.
• 6. Charles River Laboratories International, Inc.
• 7. Crown Bioscience, Inc. by JSR Corp.
• 8. Cyagen US Inc.
• 9. Envigo by Inotiv, Inc.
• 10. GemPharmatech
• 11. GenOway S.A.
• 12. Harbour Biomed
• 13. Hera BioLabs
• 14. Ingenious Targeting Laboratory
• 15. Janvier Labs
• 16. Oncodesign Precision Medicine
• 17. Ozgene Pty Ltd.
• 18. PerkinElmer, Inc.
• 19. Pharmatest Services Oy
• 20. PolyGene AG
• 21. Taconic Biosciences, Inc.
• 22. The Jackson Laboratory
• 23. TransCure Bioservices
• 24. TransViragen, Inc.
• 25. Vivo Bio Tech Ltd.